세계의 인공지능(AI) 활용 전자 환자 자가보고 결과(ePRO) 분석 시장 보고서(2025년)
Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Global Market Report 2025
상품코드 : 1889373
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,713,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,704,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,695,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

인공지능(AI) 활용 전자 환자 자가보고 결과(ePRO) 분석 시장의 규모는 최근 급속도로 확대되고 있습니다. 2024년의 15억 8,000만 달러에서 2025년에는 18억 3,000만 달러로, CAGR 15.8%로 성장할 전망입니다. 지금까지의 성장은 의료 분야에 대한 투자 증가, 환자 참여에 대한 주목 증가, 디지털 헬스 기술의 보급 확대, 임상시험 활동의 확대, 실세계 데이터(RWE)에 대한 수요 증가 등이 요인으로 추측됩니다.

인공지능(AI) 활용 전자 환자 자가보고 결과(ePRO) 분석 시장의 규모는 향후 수년간 급속한 성장이 예상됩니다. 2029년에는 32억 5,000만 달러에 달하고, CAGR은 15.5%를 나타낼 전망입니다. 예측 기간의 성장 요인으로는 실시간 환자 데이터에 대한 수요 증가, 환자 중심의 임상시험에 대한 중점 강화, 분산형 및 하이브리드형 임상시험 모델의 급증, 의료 인프라의 빠른 디지털화, 원격 의료 및 원격 환자 모니터링의 보급 확대 등이 있습니다. 예측 기간 동안 예상되는 주요 동향으로는 고급 분석을 위한 인공지능(AI)의 통합, 모바일 헬스 센서의 기술적 진보, 웨어러블 디바이스의 혁신, 웨어러블 기기에서의 AI 활용, 모바일 헬스 센서 기술의 지속적인 진전 등이 있습니다.

원격 의료 및 원격 환자 모니터링의 수용 확대는 향후 수년간 인공지능(AI) 활용 전자 환자 자가보고 결과(ePRO) 분석 시장의 성장을 이끌 것으로 예측됩니다. 원격 의료는 디지털 통신 기술을 통한 의료 서비스의 제공을 말하며, 원격 환자 모니터링은 연결 장치 및 센서에 의한 환자 건강 데이터의 지속적인 수집 및 분석을 의미합니다. 이러한 기술 활용 확대는 편리하고 접근하기 쉬우며 적시에 이루어지는 의료에 대한 수요에 의해 뒷받침되고 있습니다. 디지털 건강 플랫폼에 대한 의존도가 증가함에 따라 임상 연구에서 실시간 환자 데이터 수집과 자동화된 지식 생성을 가능하게 하는 고급 도구의 도입이 가속화되고 있습니다. 이 동향은 지속적인 고품질 데이터 수집과 지능적인 분석을 촉진함으로써 AI 활용 ePRO 분석 시장의 확대를 지원하고 있습니다. 예를 들어 2023년 12월 영국 국민보건서비스(NHS)의 발표에 따르면 월간 디지털 인터랙션 수는 대폭 증가하여 앱 이용자는 3,360만명에 이르렀고, 월간 로그인수는 전년 대비 54% 증가했습니다. 이는 디지털 의료에 대한 참여가 널리 받아들여지고 있음을 반영합니다. 이와 같이 원격 의료와 원격 환자 모니터링의 보급이 AI 활용 ePRO 분석 시장 성장을 가속화하고 있습니다.

AI 활용 ePRO 분석 시장의 주요 기업은 데이터 정밀도 향상, 임상적 판단의 신속화, 임상시험에서의 의사결정의 효율화를 도모하기 위해 AI 대응 보고서 기능 등의 혁신을 도입하고 있습니다. AI 대응 보고서 기능은 인공지능을 활용하여 복잡한 데이터세트를 자동으로 분석, 해석 및 가시화함으로써 신속하고 정밀한 인사이트를 제공하고 정보에 근거한 의사결정을 지원합니다. 예를 들어, 2025년 1월에는 미국에 본사를 둔 임상시험 기술 제공업체인 Medrio사가 자체 임상 데이터 관리 시스템 및 전자 데이터 수집(CDMS/EDC) 내에 AI 대응 보고 기능을 출시했습니다. 이 기능은 대량의 임상시험 데이터를 관리하는 연구팀을 위해 데이터 탐색을 간소화하고 핵심 EDC/CDMS 플랫폼에 직접 내장되어 있기 때문에 별도의 보고 도구가 필요 없게 되는 장점이 있습니다. 스폰서와 CRO가 참여한 Medrio의 초기 도입 프로그램은 실제 임상시험 워크플로에 대한 적합성을 보장하기 위한 기능 개발 지침이 되었습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장의 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

CSM
영문 목차

영문목차

Electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) refers to the use of AI technologies to collect, process, and interpret patient-reported data captured digitally, including symptoms, treatment experiences, quality of life, and medication adherence. AI enhances ePRO systems by uncovering patterns, predicting health risks, personalizing interventions, and providing actionable insights for clinicians, researchers, and care teams. This approach improves data accuracy, enables earlier issue detection, supports clinical decision-making, and boosts patient engagement in healthcare and clinical trials.

The main components of electronic patient-reported outcomes (ePRO) analytics with AI include software, hardware, and services. ePRO analytics software with AI consists of digital platforms that gather patient-reported information-such as symptoms, side effects, treatment responses, and quality-of-life metrics-and apply AI algorithms to analyze and interpret the data. The solution can be deployed through on-premises or cloud-based models, providing flexible data management options. It is used in clinical trials, patient monitoring, and other healthcare processes, serving end users such as pharmaceutical companies, contract research organizations, hospitals and clinics, academic and research institutions, and other healthcare organizations.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the healthcare sector, particularly in the supply of critical medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are facing higher costs for imported surgical instruments, imaging equipment, and consumables such as syringes and catheters, many of which have limited domestic alternatives. These increased costs are straining healthcare budgets, leading some providers to delay equipment upgrades or pass on expenses to patients. Additionally, tariffs on raw materials and components are disrupting the production of essential drugs and devices, causing supply chain bottlenecks. In response, the industry is diversifying sourcing strategies, boosting local manufacturing where possible, and advocating for tariff exemptions on life-saving medical products.

The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market research report is one of a series of new reports from The Business Research Company that provides electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market statistics, including electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) industry global market size, regional shares, competitors with an electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market share, detailed electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market segments, market trends and opportunities, and any further data you may need to thrive in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) industry. This electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market size has grown rapidly in recent years. It will grow from $1.58 billion in 2024 to $1.83 billion in 2025 at a compound annual growth rate (CAGR) of 15.8%. Growth in the historic period can be attributed to rising investments in healthcare, an increased focus on patient engagement, strong adoption of digital health technologies, expanding clinical trial activity, and growing demand for real-world evidence (RWE).

The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market size is expected to see rapid growth in the next few years. It will grow to $3.25 billion in 2029 at a compound annual growth rate (CAGR) of 15.5%. Growth in the forecast period can be linked to increasing demand for real-time patient data, a greater emphasis on patient-centric clinical trials, the surge in decentralized and hybrid clinical trial models, rapid digitalization of healthcare infrastructure, and wider acceptance of telemedicine and remote patient monitoring. Major trends expected during the forecast period include the integration of artificial intelligence for advanced analytics, technological advancements in mobile health sensors, innovations in wearable devices, the use of AI in wearables, and continued progress in mobile health sensor technologies.

The increasing acceptance of telemedicine and remote patient monitoring is expected to drive growth in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market in the coming years. Telemedicine involves delivering healthcare services through digital communication technologies, while remote patient monitoring entails the continuous collection and analysis of patient health data via connected devices and sensors. The growing use of these technologies is fueled by the demand for convenient, accessible, and timely care. Rising reliance on digital health platforms has accelerated the adoption of advanced tools that enable real-time patient data capture and automated insights in clinical research. This trend supports the expansion of the ePRO analytics with AI market by facilitating continuous, high-quality data collection and intelligent analysis. For example, in December 2023, the UK's National Health Service reported a significant increase in monthly digital interactions, with 33.6 million app users and a 54% rise in monthly logins compared to the previous year, reflecting broader acceptance of digital healthcare engagement. Thus, the growing adoption of telemedicine and remote patient monitoring is propelling the growth of the ePRO analytics with AI market.

Key companies in the ePRO analytics with AI market are introducing innovations such as AI-enabled reporting to improve data accuracy, accelerate clinical insights, and streamline decision-making in clinical trials. AI-enabled reporting uses artificial intelligence to automatically analyze, interpret, and visualize complex datasets, providing faster and more precise insights for informed decision-making. For instance, in January 2025, Medrio, a U.S.-based clinical trial technology provider, launched AI-enabled reporting within its clinical data management system/electronic data capture (CDMS/EDC). This feature simplifies data exploration for study teams managing large volumes of clinical trial data and is embedded directly into the core EDC/CDMS platform, reducing the need for separate reporting tools. Medrio's early adopter program, involving sponsors and CROs, guided feature development to ensure its relevance to real-world trial workflows.

In May 2024, Eli Lilly and Company, a U.S.-based global pharmaceutical firm, acquired Aparito Limited for an undisclosed amount to enhance its digital health and AI-driven ePRO capabilities. The acquisition aimed to strengthen Eli Lilly's capabilities in digital health, decentralized clinical trials, and patient-centric data collection by integrating Aparito's advanced ePRO and AI analytics technologies into its R&D processes. This supports Eli Lilly's strategy to improve clinical trial efficiency and patient engagement through real-time digital monitoring and data-driven insights. Aparito Limited, based in the U.K., provides electronic patient-reported outcomes and digital health solutions leveraging artificial intelligence, machine learning, and wearable technology to remotely capture and analyze patient data through its Atom5 platform.

Major companies operating in the electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market are Oracle Health Sciences, IQVIA Inc., Parexel International Corporation, Veeva Systems Inc., Elekta AB Kaiku Health, Clario Inc., Medidata Solutions Inc., Signant Health, eClinical Solutions LLC, Medable Inc., YPrime LLC, Kayentis SAS, uMotif Limited, Clinical Ink Inc., Curebase Inc., AiCure LLC, Climedo Health GmbH, Datacubed Health Inc., OpenClinica LLC, Castor EDC BV

North America was the largest region in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market consists of revenues earned by entities by providing services such as artificial intelligence (AI)-enabled electronic patient-reported outcomes (ePRO) platform integration, data analytics and visualization, patient engagement and support, regulatory compliance consulting, system maintenance, and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. The electronic patient-reported outcomes (ePRO) analytics with artificial intelligence (AI) market also includes sales of artificial intelligence (AI)-powered electronic patient-reported outcomes (ePRO) software platform, mobile electronic patient-reported outcomes (ePRO) data collection app, cloud-based electronic patient-reported outcomes (ePRO) analytics dashboard, wearable-integrated patient monitoring tool, and artificial intelligence (AI)-driven clinical trial reporting system. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The electronic patient-reported outcomes (epro) analytics with artificial intelligence (ai) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Characteristics

3. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Trends And Strategies

4. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Growth Analysis And Strategic Analysis Framework

6. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Segmentation

7. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Regional And Country Analysis

8. Asia-Pacific Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

9. China Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

10. India Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

11. Japan Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

12. Australia Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

13. Indonesia Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

14. South Korea Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

15. Western Europe Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

16. UK Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

17. Germany Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

18. France Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

19. Italy Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

20. Spain Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

21. Eastern Europe Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

22. Russia Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

23. North America Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

24. USA Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

25. Canada Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

26. South America Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

27. Brazil Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

28. Middle East Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

29. Africa Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

30. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Competitive Landscape And Company Profiles

31. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Other Major And Innovative Companies

32. Global Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

34. Recent Developments In The Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market

35. Electronic Patient-Reported Outcomes (ePRO) Analytics With Artificial Intelligence (AI) Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기